LIMK1 and prostate carcinoma: For example, an immunohistochemical (IHC) study in prostate cancer found an association between the amount of nuclear LIMK1, higher Gleason scores, and incidence of metastasis [19], suggesting that nuclear LIMK1 may contribute to progression of human cancer.